Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Remdesivir metabolite GS-441524 may be superior for eradicating SARS-CoV-2

April 13, 2021

Positive phase II data for mavrilimumab in nonmechanically ventilated severe COVID-19

April 13, 2021

New antibiotic prodrugs synthesized at Brandeis University

April 13, 2021

Phase III DARE-19 study of Farxiga in COVID-19 does not meet primary endpoints

April 13, 2021

Moderna initiates phase I study of its COVID-19 variant vaccine mRNA-1273.351

April 12, 2021

Enrollment begins in phase II study of ATR-002 in hospitalized patients with COVID-19

April 9, 2021

Phase II study of zanubrutinib in COVID-19 misses coprimary efficacy endpoints

April 9, 2021

Phase III COV-BARRIER study of baricitinib in COVID-19 does not meet primary endpoint

April 9, 2021

Enrollment ongoing in phase II/III study of pyronaridine/artesunate for the treatment of COVID-19

April 9, 2021

NIH initiates study to assess allergic reactions to Moderna and Pfizer-BioNTech COVID-19 vaccines

April 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...